DWA
RETA

Delos Wealth Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Delos Wealth Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,600
Closed -$148K – 450
2021
Q4 		$148K Sell
5,600
-1,150
-17% -$30.4K 0.14% 45
2021
Q3 		$679K Hold
6,750
– – 0.75% 34
2021
Q2 		$955K Buy
+6,750
New +$955K 1.19% 29